Real-time enrollment status for this renal cell carcinoma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 11:16 PM UTC
| NCT Number | NCT07223424 |
| Recruiting Status | Recruiting |
| Condition | Renal Cell Carcinoma |
| Phase | PHASE2 |
| Target Enrollment | 880 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Diwakar Davar |
| Last Updated on CT.gov | April 16, 2026 (Apr 16, 2026) |
As of July 17, 2026: Clinical trial NCT07223424 is currently recruiting participants. This phase2 study for renal cell carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Diwakar Davar. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07223424 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07223424 was last updated Apr 16, 2026 (April 16, 2026). HelloStudys verifies this status automatically.